Related Experiment Video
Updated: Aug 2, 2025

07:13
ATAC-Seq Optimization for Cancer Epigenetics Research
Published on: June 30, 2022
4.4K
Protocol for Bulk-ATAC sequencing in head and neck squamous cell carcinoma
Nana Chen1, Manik Vohra2, Srinivas Vinod Saladi2
1Department of Otolaryngology, Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Head and Neck Lab, 20 Staniford Street 2W, Boston, MA 02114, USA.
STAR Protocols
|April 18, 2023
Summary
This study optimizes the transposase-accessible chromatin using sequencing (ATAC-seq) protocol for head and neck cancer research. The method reveals epigenetic changes in cancer cells, aiding in understanding treatment responses.
Area of Science:
- Epigenetics
- Genomics
- Cancer Biology
Background:
- Chromatin accessibility is crucial for understanding gene regulation in cancer.
- Transposase-accessible chromatin using sequencing (ATAC-seq) provides insights into open chromatin regions.
- Head and neck squamous cell carcinoma (HNSCC) requires refined molecular profiling methods.
Purpose of the Study:
- To present an optimized ATAC-seq protocol tailored for HNSCC cells.
- To elucidate chromatin accessibility changes at the epigenetic level in HNSCC.
- To provide a detailed methodology for researchers in the field.
Main Methods:
- Optimization of cell lysate preparation, transposition, and tagmentation steps.
- Detailed protocol for library amplification and purification.
- Guidelines for next-generation sequencing and data analysis of ATAC-seq libraries.
Main Results:
- The optimized protocol enables sensitive detection of chromatin accessibility.
- The method effectively identifies epigenetic alterations in HNSCC cells.
- Successful application of ATAC-seq for studying cancer cell responses to interventions.
Conclusions:
- The optimized ATAC-seq protocol is a valuable tool for HNSCC epigenetic research.
- This method facilitates the study of chromatin dynamics in cancer.
- The protocol supports the investigation of genetic and drug-induced changes in cancer cells.

